Towards an integrated understanding of epidermal growth factor receptor biology for radiation therapy: integrins enter

J Natl Cancer Inst. 2015 Feb 5;107(2):dju440. doi: 10.1093/jnci/dju440. Print 2015 Feb.

Authors

Henning Willers¹, Theodore S Hong²

Affiliations

¹ Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (HW, TSH). hwillers@mgh.harvard.edu.
² Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (HW, TSH).

PMID: 25663686
DOI: 10.1093/jnci/dju440

No abstract available

Publication types

Editorial
Comment

MeSH terms

Animals
Antibodies, Monoclonal / pharmacology*
Antineoplastic Combined Chemotherapy Protocols / pharmacology*
Carcinoma, Squamous Cell / therapy*
ErbB Receptors / antagonists & inhibitors*
Head and Neck Neoplasms / therapy*
Humans
Integrin beta1 / drug effects*
Molecular Targeted Therapy / methods*
Squamous Cell Carcinoma of Head and Neck

Substances

Antibodies, Monoclonal
Integrin beta1
EGFR protein, human
ErbB Receptors